Divergent effects of resveratrol, a polyphenolic phytostilbene, on free radical levels and type of cell death induced by the histone deacetylase inhibitors butyrate and trichostatin A

Journal of Steroid Biochemistry and Molecular Biology

Volumn 94, Issue 1-3 SPEC. ISS., 2005, Pages 39-47

  Galfi, Peter ^a   Jakus, Judit ^b   Molnar, Tamas ^a   Neogrady, Susan ^a   Csordas, Adam ^c  

^a SZENT ISTVÁN UNIVERSITY   (Hungary)

^b CHEMICAL RESEARCH CENTER   (Hungary)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Antioxidant; Apoptosis; Butyrate; ESR; Free radicals; Histone deacetylase inhibitor; N acetylcystein; Necrosis; Polyphenol; Pro oxidant; Resveratrol; Stilbene; Trichostatin A

Indexed keywords

ACETYLCYSTEINE; BUTYRIC ACID; FREE RADICAL; HISTONE DEACETYLASE INHIBITOR; POLYPHENOL DERIVATIVE; RESVERATROL; STILBENE DERIVATIVE; TRICHOSTATIN A;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL DEATH; CELL PROTECTION; CELL TYPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; RAT;

EID: 18144403173     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2004.12.019     Document Type: Article

References (34)

1. L. Fremont Biological effects of resveratrol Life Sci. 66 2000 663 673
2. S. Pervaiz Resveratrol: from grapevines to mammalian biology FASEB J. 17 2003 1975 1985
3. F. Bianchini, and H. Vainio Wine and resveratrol: mechanisms of cancer prevention? Eur. J. Cancer Prev. 12 2003 417 425
4. V. Granados-Soto Pleiotropic effects of resveratrol Drug News Perspect. 16 2003 299 307
5. M.H. Aziz, R. Kumar, and N. Ahmad Cancer chemoprevention by resveratrol: in vitro and in vivo studies and underlying mechanisms Int. J. Oncol. 23 2003 17 28
6. D. Bernhard, I. Tinhofer, M. Tonko, H. Hübl, M.J. Ausserlechner, R. Greil, R. Kofler, and A. Csordas Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukaemia cells Cell Death Differ. 7 2000 834 842
7. E. Pozo-Guisado, A. Alvarez-Barrientos, S. Mulero-Navarro, B. Santiago-Josefat, and P.M. Fernandez-Salguero The antiproliferative activity of resveratrol results in apoptosis in MCF-F7 but not in MDA-MB-231 human breast cancer cells: cell-specific alteration of the cell cycle Biochem. Pharmacol. 64 2002 1375 1386
8. X.Z. Ding, and T.E. Adrian Resveratrol inhibits proliferation and induces apoptosis in human pancreatic cancer cells Pancreas 25 2002 e71 e76
9. V. Cardile, C. Scifo, A. Russo, M. Falsaperla, G. Morgia, M. Motta, M. Renis, E. Imbriani, and G. Sivestre Involvement of HSP70 in resveratrol-induced apoptosis of human prostate cancer Anticancer Res. 23 2003 4921 4926
10. F. Scarlatti, G. Sala, G. Somenzi, P. Signorelli, N. Sacchi, and R. Ghidoni Resveratrol induces growth inhibition and apoptosis in metastatic breast cancer cells via de novo ceramide signaling FASEB J. 17 2003 2339 2341 (Epub. 2003, October 16)
11. A.W. Opipari Jr., L. Tan, A.E. Boitano, D.R. Sorenson, A. Aurora, and J.R. Liu Resveratrol-induced autophagocytosis in ovarian cancer cells Cancer Res. 64 2004 696 703
12. M. Maccarrone, T. Lorenzon, P. Guerrieri, and A.F. Agro Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity Eur. J. Biochem. 265 1999 27 34
13. B. Szende, E. Tyihak, and Z. Kiraly-Veghely Dose-dependent effect of resveratrol on proliferation and apoptosis in endothelial and tumor cell cultures Exp. Mol. Med. 32 2000 88 92
14. K.A. Ahmad, M.V. Clement, I.M. Hanif, and S. Pervaiz Resveratrol inhibits drug-induced apoptosis in human leukaemia cells by creating an intracellular milieu nonpermissive for death execution Cancer Res. 64 2004 1452 1459
15. 2 and vanadate stimulate protein tyrosine phosphorylation in intact cells J. Biol. Chem. 265 1990 2896 2902
16. R.H. Burdon Superoxide and hydrogen peroxide in relation to mammalian proliferation Free Radic. Biol. Med. 18 1995 775 794
17. H. Sauer, M. Wartenberg, and J. Hescheler Reactive oxygen species as intracellular messengers during cell growth Cell Physiol. Biochem. 11 2001 173 186
18. W. Droge Free radicals in the physiological control of cell function Physiol. Rev. 82 2002 47 95
19. R. Lu, and G. Serrero Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells J. Cell Physiol. 179 1999 297 304
20. J.L. Bowers, V.V. Tyulmelkov, S.C. Jernigan, and C.M. Klinge Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta Endocrinology 141 2000 3657 3667
21. K. Bhat, D. Lantvit, K. Christov, R.G. Meta, R. Moon, and J. Pezzuto Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models Cancer Res. 61 2001 7456 7463
22. E. Pozo-Guisado, M.J. Lorenzo-Benayas, and P.M. Fernandez-Salguero Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: relevance in cell proliferation Int. J. Cancer 1009 2004 167 173
23. M. Jang, L. Cai, G.O. Udeani, K.V. Slowing, C.F. Thomas, C.W.W. Beecher, H.H.S. Fong, N.R. Farnsworth, A.D. Kinghorn, R.G. Mehta, R.C. Moon, and J.M. Pezzuto Cancer chemopreventive activity of resveratrol, a natural product derived from grapes Science 275 1997 218 220
24. L.M. Szewczuk, L. Forti, L.A. Stivala, and T.M. Penning Resveratrol is a peroxidasemediated inactivator of COX-1 but not COX-2: a mechanistic approach to the design of COX-1 selective agents J. Biol. Chem. 279 2004 22727 22737 (Epub. 2004, March 12)
25. K. Subbaramaiah, W.J. Chung, P. Michaluart, N. Telang, T. Tanabe, H. Inoue, M. Jang, J.M. Pezzuto, and A.J. Dannenberg Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells J. Biol. Chem. 273 1998 21875 21882
26. T. Shulyakovskaya, L. Sümegi, and D. Gál In vivo experimental studies on the role of free radicals in photodynamic therapy. I. Measurement of the steady state concentration of free radicals in tumor tissues of mice Biochem. Biophys. Res. Commun. 195 1993 581 587
27. L. Quaio, R. Hanif, E. Sphicas, S.J. Shiff, and B. Rigas Effect of aspirin on induction of apoptosis in HT-29 human colon adenocarcinoma cells Biochem. Pharmacol. 55 1998 53 64
28. P. Galfi, S. Neogrady, and F. Kutas The inhibitory action of sodium butyrate on the growth of KB, MMT and RPMI cells Vet. Res. Commun. 15 1991 261 269
29. P. Galfi, Zs. Neogrady, and A. Csordas Apoptosis sensitivity is not correlated with sensitivity to proliferation inhibition by the histone deacetylase inhibitors butyrate and TSA Cancer Lett. 188 2002 141 152
30. A. Bertelli, A.A.E. Bertelli, A. Gozzini, and L. Giovannini Plasma and tissue resveratrol concentration and pharmacological activity Drugs Exp. Clin. Res. 24 1998 133 138
31. X. Meng, P. Maliakal, H. Lu, M.J. Lee, and C.S. Yang Urinary and plasma levels of resveratrol and quercetin in humans, mice and rats after ingestion of pure compounds and grape juice J. Agric. Food Chem. 52 2004 935 942
32. A.J. Gescher, and W.P. Steward Relationship between mechanisms, bioavailability, and preclinical chemopreventive efficacy of resveratrol: a conundrum Cancer Epidemiol. Biomarkers Prev. 12 2003 953 957
33. M. Asensi, I. Medina, A. Ortega, J. Carretero, M.C. Bano, E. Obrador, and J.M. Estrela Inhibition of cancer growth by resveratrol is related to its low bioavailability Free Radic. Biol. Med. 33 2002 387 398
34. S. Sale, R.D. Verschoyle, D. Boocock, D.J. Jones, N. Wilsher, K.C. Ruparelia, G.A. Potter, P.B. Farmer, W.P. Steward, and A.J. Gescher Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans-3,4,5,4′-tetramethoxystilbene Br. J. Cancer 90 2004 736 744